ID   THTM_RAT                Reviewed;         297 AA.
AC   P97532;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   29-MAY-2024, entry version 153.
DE   RecName: Full=3-mercaptopyruvate sulfurtransferase;
DE            Short=MST;
DE            EC=2.8.1.2 {ECO:0000269|PubMed:8910318, ECO:0000269|PubMed:9749958};
GN   Name=Mpst;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 9-77 AND 147-285, ACTIVE
RP   SITE, MUTAGENESIS OF ARG-188; ARG-197; CYS-248 AND SER-250, FUNCTION, AND
RP   CATALYTIC ACTIVITY.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8910318; DOI=10.1074/jbc.271.44.27395;
RA   Nagahara N., Nishino T.;
RT   "Role of amino acid residues in the active site of rat liver
RT   mercaptopyruvate sulfurtransferase. cDNA cloning, overexpression, and site-
RT   directed mutagenesis.";
RL   J. Biol. Chem. 271:27395-27401(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 9-77 AND 147-285, AND CHARACTERIZATION.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=7608189; DOI=10.1074/jbc.270.27.16230;
RA   Nagahara N., Okazaki T., Nishino T.;
RT   "Cytosolic mercaptopyruvate sulfurtransferase is evolutionarily related to
RT   mitochondrial rhodanese. Striking similarity in active site amino acid
RT   sequence and the increase in the mercaptopyruvate sulfurtransferase
RT   activity of rhodanese by site-directed mutagenesis.";
RL   J. Biol. Chem. 270:16230-16235(1995).
RN   [4]
RP   PROTEIN SEQUENCE OF 53-64 AND 119-164, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=9749958; DOI=10.1007/s004180050286;
RA   Nagahara N., Ito T., Kitamura H., Nishino T.;
RT   "Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase
RT   in the rat: confocal laser fluorescence and immunoelectron microscopic
RT   studies combined with biochemical analysis.";
RL   Histochem. Cell Biol. 110:243-250(1998).
RN   [6]
RP   FUNCTION, ACTIVITY REGULATION, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   MUTAGENESIS OF CYS-65; CYS-155; CYS-248; CYS-255 AND CYS-264.
RX   PubMed=16107337; DOI=10.1074/jbc.m505643200;
RA   Nagahara N., Katayama A.;
RT   "Post-translational regulation of mercaptopyruvate sulfurtransferase via a
RT   low redox potential cysteine-sulfenate in the maintenance of redox
RT   homeostasis.";
RL   J. Biol. Chem. 280:34569-34576(2005).
RN   [7]
RP   ACTIVITY REGULATION, AND SUBUNIT.
RX   PubMed=17130129; DOI=10.1074/jbc.m605931200;
RA   Nagahara N., Yoshii T., Abe Y., Matsumura T.;
RT   "Thioredoxin-dependent enzymatic activation of mercaptopyruvate
RT   sulfurtransferase. An intersubunit disulfide bond serves as a redox switch
RT   for activation.";
RL   J. Biol. Chem. 282:1561-1569(2007).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19605461; DOI=10.1093/jb/mvp111;
RA   Shibuya N., Mikami Y., Kimura Y., Nagahara N., Kimura H.;
RT   "Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and
RT   produces hydrogen sulfide.";
RL   J. Biochem. 146:623-626(2009).
CC   -!- FUNCTION: Transfer of a sulfur ion to cyanide or to other thiol
CC       compounds. Also has weak rhodanese activity. Detoxifies cyanide and is
CC       required for thiosulfate biosynthesis. Acts as an antioxidant. In
CC       combination with cysteine aminotransferase (CAT), contributes to the
CC       catabolism of cysteine and is an important producer of hydrogen sulfide
CC       in the brain, retina and vascular endothelial cells. Hydrogen sulfide
CC       H(2)S is an important synaptic modulator, signaling molecule, smooth
CC       muscle contractor and neuroprotectant. Its production by the 3MST/CAT
CC       pathway is regulated by calcium ions. {ECO:0000269|PubMed:16107337,
CC       ECO:0000269|PubMed:19605461, ECO:0000269|PubMed:8910318,
CC       ECO:0000269|PubMed:9749958}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxo-3-sulfanylpropanoate + [thioredoxin]-dithiol =
CC         [thioredoxin]-disulfide + H(+) + hydrogen sulfide + pyruvate;
CC         Xref=Rhea:RHEA:21740, Rhea:RHEA-COMP:10698, Rhea:RHEA-COMP:10700,
CC         ChEBI:CHEBI:15361, ChEBI:CHEBI:15378, ChEBI:CHEBI:29919,
CC         ChEBI:CHEBI:29950, ChEBI:CHEBI:50058, ChEBI:CHEBI:57678; EC=2.8.1.2;
CC         Evidence={ECO:0000269|PubMed:8910318, ECO:0000269|PubMed:9749958};
CC   -!- ACTIVITY REGULATION: By oxidative stress, and thioredoxin. Under
CC       oxidative stress conditions, the catalytic cysteine site is converted
CC       to a sulfenate which inhibits the MPST enzyme activity. Reduced
CC       thioredoxin cleaves an intersubunit disulfide bond to turn on the redox
CC       switch and reactivate the enzyme. Inhibited by different oxidants,
CC       hydrogen peroxide and tetrathionate. {ECO:0000269|PubMed:16107337,
CC       ECO:0000269|PubMed:17130129}.
CC   -!- SUBUNIT: Monomer (active form). Homodimer; disulfide-linked (inactive
CC       form). {ECO:0000269|PubMed:17130129}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9749958}.
CC       Mitochondrion {ECO:0000269|PubMed:9749958}. Synapse, synaptosome
CC       {ECO:0000250|UniProtKB:Q99J99}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver, heart, kidney and brain.
CC       Localizes to tubular epithelium in the kidney, pericentral hepatocytes
CC       in the liver, cardiac cells in the heart and neuroglial cells in the
CC       brain. Also expressed in vascular endothelium of the thoracic aorta.
CC       Weak expression in lung and thymus. {ECO:0000269|PubMed:19605461,
CC       ECO:0000269|PubMed:9749958}.
CC   -!- DOMAIN: Contains two rhodanese domains with different primary
CC       structures but with near identical secondary structure conformations
CC       suggesting a common evolutionary origin. Only the C-terminal rhodanese
CC       domain contains the catalytic cysteine residue (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- MISCELLANEOUS: Thioredoxin (Trx) or dihydrolipoic acid (DHLA) are
CC       required to release hydrogen sulfide from the persulfide intermediate.
CC       {ECO:0000250|UniProtKB:Q99J99}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D50564; BAA09127.1; -; mRNA.
DR   EMBL; BC086575; AAH86575.1; -; mRNA.
DR   PIR; A57483; A57483.
DR   RefSeq; NP_620198.1; NM_138843.1.
DR   AlphaFoldDB; P97532; -.
DR   SMR; P97532; -.
DR   STRING; 10116.ENSRNOP00000000201; -.
DR   iPTMnet; P97532; -.
DR   PhosphoSitePlus; P97532; -.
DR   SwissPalm; P97532; -.
DR   jPOST; P97532; -.
DR   PaxDb; 10116-ENSRNOP00000000201; -.
DR   Ensembl; ENSRNOT00000000201.6; ENSRNOP00000000201.2; ENSRNOG00000000185.6.
DR   Ensembl; ENSRNOT00055055416; ENSRNOP00055045741; ENSRNOG00055032040.
DR   Ensembl; ENSRNOT00060053015; ENSRNOP00060044072; ENSRNOG00060030521.
DR   Ensembl; ENSRNOT00065057305; ENSRNOP00065047146; ENSRNOG00065033335.
DR   GeneID; 192172; -.
DR   KEGG; rno:192172; -.
DR   UCSC; RGD:620065; rat.
DR   AGR; RGD:620065; -.
DR   CTD; 4357; -.
DR   RGD; 620065; Mpst.
DR   eggNOG; KOG1529; Eukaryota.
DR   GeneTree; ENSGT00510000046773; -.
DR   HOGENOM; CLU_031618_3_1_1; -.
DR   InParanoid; P97532; -.
DR   OMA; QRPGHVP; -.
DR   OrthoDB; 5488838at2759; -.
DR   PhylomeDB; P97532; -.
DR   TreeFam; TF315133; -.
DR   BioCyc; MetaCyc:MONOMER-12473; -.
DR   BRENDA; 2.8.1.2; 5301.
DR   Reactome; R-RNO-1614558; Degradation of cysteine and homocysteine.
DR   SABIO-RK; P97532; -.
DR   PRO; PR:P97532; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000000185; Expressed in adult mammalian kidney and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0016784; F:3-mercaptopyruvate sulfurtransferase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IDA:RGD.
DR   GO; GO:0004792; F:thiosulfate sulfurtransferase activity; IDA:RGD.
DR   GO; GO:0070814; P:hydrogen sulfide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IDA:RGD.
DR   GO; GO:0001889; P:liver development; IDA:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0019346; P:transsulfuration; IDA:RGD.
DR   CDD; cd01448; TST_Repeat_1; 1.
DR   CDD; cd01449; TST_Repeat_2; 1.
DR   Gene3D; 3.40.250.10; Rhodanese-like domain; 2.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   InterPro; IPR036873; Rhodanese-like_dom_sf.
DR   InterPro; IPR001307; Thiosulphate_STrfase_CS.
DR   InterPro; IPR045078; TST/MPST-like.
DR   PANTHER; PTHR11364:SF25; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; 1.
DR   PANTHER; PTHR11364; THIOSULFATE SULFERTANSFERASE; 1.
DR   Pfam; PF00581; Rhodanese; 2.
DR   SMART; SM00450; RHOD; 2.
DR   SUPFAM; SSF52821; Rhodanese/Cell cycle control phosphatase; 2.
DR   PROSITE; PS00380; RHODANESE_1; 1.
DR   PROSITE; PS00683; RHODANESE_2; 1.
DR   PROSITE; PS50206; RHODANESE_3; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   Mitochondrion; Phosphoprotein; Redox-active center; Reference proteome;
KW   Repeat; Synapse; Synaptosome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P25325"
FT   CHAIN           2..297
FT                   /note="3-mercaptopyruvate sulfurtransferase"
FT                   /id="PRO_0000139400"
FT   DOMAIN          25..144
FT                   /note="Rhodanese 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00173"
FT   DOMAIN          174..288
FT                   /note="Rhodanese 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00173"
FT   REGION          145..160
FT                   /note="Hinge"
FT   ACT_SITE        248
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00173,
FT                   ECO:0000269|PubMed:8910318"
FT   BINDING         188
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P25325"
FT   MOD_RES         35
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P25325"
FT   MOD_RES         40
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J99"
FT   MOD_RES         40
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J99"
FT   MOD_RES         146
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J99"
FT   MOD_RES         164
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99J99"
FT   DISULFID        155
FT                   /note="Interchain (with C-155 or C-264); redox-active"
FT                   /evidence="ECO:0000250"
FT   DISULFID        264
FT                   /note="Interchain (with C-155 or C-264); redox-active"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         65
FT                   /note="C->S: No effect on redox potential."
FT                   /evidence="ECO:0000269|PubMed:16107337"
FT   MUTAGEN         155
FT                   /note="C->S: No effect on redox potential."
FT                   /evidence="ECO:0000269|PubMed:16107337"
FT   MUTAGEN         188
FT                   /note="R->G: Large decrease in MST activity; some decrease
FT                   in rhodanese activity."
FT                   /evidence="ECO:0000269|PubMed:8910318"
FT   MUTAGEN         197
FT                   /note="R->G: Decreased MST activity; increased rhodanese
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:8910318"
FT   MUTAGEN         248
FT                   /note="C->S: Loss of both enzyme activities. Greatly
FT                   reduced redox potential."
FT                   /evidence="ECO:0000269|PubMed:16107337,
FT                   ECO:0000269|PubMed:8910318"
FT   MUTAGEN         249
FT                   /note="G->R: Decreased MST activity; increased rhodanese
FT                   activity."
FT   MUTAGEN         250
FT                   /note="S->A: Slight decrease in MST activity."
FT                   /evidence="ECO:0000269|PubMed:8910318"
FT   MUTAGEN         250
FT                   /note="S->K: Slight decrease in MST activity; increased
FT                   rhodanese activity."
FT                   /evidence="ECO:0000269|PubMed:8910318"
FT   MUTAGEN         255
FT                   /note="C->S: Little change in redox potential."
FT                   /evidence="ECO:0000269|PubMed:16107337"
FT   MUTAGEN         264
FT                   /note="C->S: Greatly reduced redox potential."
FT                   /evidence="ECO:0000269|PubMed:16107337"
SQ   SEQUENCE   297 AA;  32940 MW;  314E2B8EAFDEFB77 CRC64;
     MAAPQLFRAL VSAQWVAEAL KSPRASQPLK LLDASWYLPK LGRDARREFE ERHIPGAAFF
     DIDRCSDHTS PYDHMLPSAT HFADYAGSLG VSAATHVVIY DGSDQGLYSA PRVWWMFRAF
     GHHSVSLLDG GFRYWLSQNL PISSGKSPSE PAEFCAQLDP SFIKTHEDIL ENLDARRFQV
     VDARAAGRFQ GTQPEPRDGI EPGHIPGSVN IPFTEFLTSE GLEKSPEEIQ RLFQEKKVDL
     SKPLVATCGS GVTACHVVLG AFLCGKPDVP VYDGSWVEWY MRAQPEHVIS QGRGKTL
//
